Alaunos Therapeutics | ZIOP - Pre Tax Profit


Alaunos Therapeutics reported $-7.84M in Pre-Tax Profit for its fiscal quarter ending in December of 2023.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 3.92B 2.35B Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Baxter International USD 121M 12M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Bioline Rx USD -977K 2.96M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Celltrion KRW 14.6B 180.89B Jun/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Curis USD -13.99M 7.38M Jun/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Incyte USD 389.94M 92.37M Dec/2025
Intrexon USD -60.48M 27.09M Jun/2024
Ionis Pharmaceuticals USD -228M 99M Dec/2025
J&J USD 4.97B 2.53B Dec/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Karyopharm Therapeutics USD -30.89M 1.16M Dec/2024
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Merck USD 6.74B 22M Sep/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Novartis USD 4.64B 445M Dec/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Pharma Mar EUR 40.2M 44.28M Dec/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sartorius EUR 85M 14.1M Sep/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025
Tilray USD -39.96M 39.19M Sep/2025
Verastem USD -33.86M 6.49M Mar/2024
Zealand Pharma A/S -406.5M 39.77M Dec/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025